American Heart Journal
Volume 154, Issue 1 , Pages 39-45 , July 2007

Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: Design and rationale for the MULTI-STRATEGY trial

  • Marco Valgimigli, MD, PhD

      Affiliations

    • Cardiology, University of Ferrara, Ferrara, Italy
    • Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS Gussago, Brescia, Italy
    • Corresponding Author InformationReprint requests: Marco Valgimigli, MD, PhD, Cardiology, University of Ferrara, Cardiovascular Institute, Arcispedale S. Anna Hospital, C.rso Giovecca 203, 44100 Ferrara, Italy.
    • ,
  • Leonardo Bolognese, MD

      Affiliations

    • Cardiovascular Departments of San Donato Hospital, Arezzo, Italy
    • ,
  • Maurizio Anselmi, MD

      Affiliations

    • Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Verona, Italy
    • ,
  • Gianluca Campo, MD

      Affiliations

    • Cardiology, University of Ferrara, Ferrara, Italy
    • ,
  • Alfredo E. Rodriguez, MD, PhD

      Affiliations

    • Otamendi Hospital, Buenos Aires, Argentina
    • ,
  • Nicoletta de Cesare, MD

      Affiliations

    • Policlinico S. Marco, Zingonia, Bergamo, Italy
    • ,
  • David J. Cohen, MD, MSc

      Affiliations

    • Saint Luke's Mid America Heart Institute, Kansas City, MO
    • ,
  • Imad Sheiban, MD

      Affiliations

    • Interventional Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    • ,
  • Salvatore Colangelo, MD

      Affiliations

    • Cardiovascular Intervention Laboratory San Giovanni Bosco Hospital, Turin, Italy
    • ,
  • Giampaolo Pasquetto, MD

      Affiliations

    • Department of Cardiology, Civic Hospital, Mirano, Venice, Italy
    • ,
  • Martial Hamon, MD

      Affiliations

    • Department at the University Hospital of Caen, Normandy, France
    • ,
  • Pascal Vranckx, MD

      Affiliations

    • Virga Jesseziekenhuis, Hasselt, Belgium
    • ,
  • Maurizio Ferrario, MD

      Affiliations

    • Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico S. Matteo, Pavia, Italy
    • ,
  • Francesco Prati, MD, PhD

      Affiliations

    • Department of Cardiovascular Medicine, Catholic University of the Sacred heart, Rome, Italy
    • ,
  • Pierfrancesco Agostoni, MD

      Affiliations

    • Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium
    • ,
  • Patrizia Malagutti, MD

      Affiliations

    • Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS Gussago, Brescia, Italy
    • ,
  • Chiara Arcozzi, MD

      Affiliations

    • Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS Gussago, Brescia, Italy
    • ,
  • Giovanni Parrinello, PhD

      Affiliations

    • Medical Statistics Unit, University of Brescia, Italy
    • ,
  • Corrado Vassanelli, MD

      Affiliations

    • Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Verona, Italy
    • ,
  • Roberto Ferrari, MD, PhD

      Affiliations

    • Cardiology, University of Ferrara, Ferrara, Italy
    • Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS Gussago, Brescia, Italy
    • ,
  • Gianfranco Percoco, MD

      Affiliations

    • Cardiology, University of Ferrara, Ferrara, Italy

Received 16 December 2006 ,Accepted 15 March 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The conduct of this study was partially supported by Merck Company (Whitehouse Station, NJ).

PII: S0002-8703(07)00245-1

doi: 10.1016/j.ahj.2007.03.023

American Heart Journal
Volume 154, Issue 1 , Pages 39-45 , July 2007

Article Tools

* Image Usage & Resolution